May 11, 2015
by goldwater
Originally posted in PBS by Stephen Fee Drugmaker Johnson & Johnson said today that it would tap bioethicist Arthur Caplan of the NYU School of Medicine to lead an independent group overseeing requests from dying patients to use experimental medications. The company says the panel will be the first of its kind, advising J&J subsidiary […]
Read More ›